Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.23 - $7.4 $40,307 - $92,344
-12,479 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$5.61 - $13.85 $70,007 - $172,834
12,479 New
12,479 $76,000
Q1 2022

May 20, 2022

SELL
$5.61 - $13.85 $8,173 - $20,179
-1,457 Reduced 10.45%
12,479 $76,000
Q4 2021

Feb 16, 2022

BUY
$10.52 - $16.96 $146,606 - $236,354
13,936 New
13,936 $175,000

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $55.5M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.